FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387609716> ?p ?o ?g. }

• W4387609716 abstract "Introduction Triple-negative breast cancer (TNBC) comprises a heterogeneous group of clinically aggressive tumors with high risk of recurrence and metastasis. Current pharmacological treatment options remain largely limited to chemotherapy. Despite promising results, the efficacy of immunotherapy and chemo-immunotherapy in TNBC remains limited. There is strong evidence supporting the involvement of Notch signaling in TNBC progression. Expression of Notch1 and its ligand Jagged1 correlate with poor prognosis. Notch inhibitors, including g-secretase inhibitors (GSIs), are quite effective in preclinical models of TNBC. However, the success of GSIs in clinical trials has been limited by their intestinal toxicity and potential for adverse immunological effects, since Notch plays key roles in T-cell activation, including CD8 T-cells in tumors. Our overarching goal is to replace GSIs with agents that lack their systemic toxicity and ideally, do not affect tumor immunity. We identified sulindac sulfide (SS), the active metabolite of FDA-approved NSAID sulindac, as a potential candidate to replace GSIs. Methods We investigated the pharmacological and immunotherapeutic properties of SS in TNBC models in vitro , ex-vivo and in vivo . Results We confirmed that SS, a known γ-secretase modulator (GSM), inhibits Notch1 cleavage in TNBC cells. SS significantly inhibited mammosphere growth in all human and murine TNBC models tested. In a transplantable mouse TNBC tumor model (C0321), SS had remarkable single-agent anti-tumor activity and eliminated Notch1 protein expression in tumors. Importantly, SS did not inhibit Notch cleavage in T- cells, and the anti-tumor effects of SS were significantly enhanced when combined with a-PD1 immunotherapy in our TNBC organoids and in vivo . Discussion Our data support further investigation of SS for the treatment of TNBC, in conjunction with chemo- or -chemo-immunotherapy. Repurposing an FDA-approved, safe agent for the treatment of TNBC may be a cost-effective, rapidly deployable therapeutic option for a patient population in need of more effective therapies." @default.
• W4387609716 created "2023-10-14" @default.
• W4387609716 creator A5022819121 @default.
• W4387609716 creator A5023610125 @default.
• W4387609716 creator A5030375542 @default.
• W4387609716 creator A5030449403 @default.
• W4387609716 creator A5041222618 @default.
• W4387609716 creator A5041301571 @default.
• W4387609716 creator A5045940484 @default.
• W4387609716 creator A5047070829 @default.
• W4387609716 creator A5048983251 @default.
• W4387609716 creator A5051275013 @default.
• W4387609716 creator A5056296095 @default.
• W4387609716 creator A5058688886 @default.
• W4387609716 creator A5059258803 @default.
• W4387609716 creator A5063369663 @default.
• W4387609716 creator A5063837076 @default.
• W4387609716 creator A5079106210 @default.
• W4387609716 creator A5080769954 @default.
• W4387609716 creator A5081286017 @default.
• W4387609716 creator A5083785482 @default.
• W4387609716 creator A5084369103 @default.
• W4387609716 creator A5087467543 @default.
• W4387609716 date "2023-10-13" @default.
• W4387609716 modified "2023-10-14" @default.
• W4387609716 title "Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer" @default.
• W4387609716 cites W1058934875 @default.
• W4387609716 cites W1522302858 @default.
• W4387609716 cites W1587652097 @default.
• W4387609716 cites W1608726418 @default.
• W4387609716 cites W1656241491 @default.
• W4387609716 cites W183361337 @default.
• W4387609716 cites W1861730929 @default.
• W4387609716 cites W1964246992 @default.
• W4387609716 cites W1965532883 @default.
• W4387609716 cites W1967211245 @default.
• W4387609716 cites W1969876120 @default.
• W4387609716 cites W1979892584 @default.
• W4387609716 cites W1983849161 @default.
• W4387609716 cites W1984365236 @default.
• W4387609716 cites W1986329074 @default.
• W4387609716 cites W1991212258 @default.
• W4387609716 cites W2003654564 @default.
• W4387609716 cites W2006070115 @default.
• W4387609716 cites W2006818027 @default.
• W4387609716 cites W2011905697 @default.
• W4387609716 cites W2014540164 @default.
• W4387609716 cites W2016186952 @default.
• W4387609716 cites W2017137665 @default.
• W4387609716 cites W2029765217 @default.
• W4387609716 cites W2032095580 @default.
• W4387609716 cites W2038554369 @default.
• W4387609716 cites W2039109621 @default.
• W4387609716 cites W2053654678 @default.
• W4387609716 cites W2054047572 @default.
• W4387609716 cites W2058298545 @default.
• W4387609716 cites W2065731223 @default.
• W4387609716 cites W2066615317 @default.
• W4387609716 cites W2068327832 @default.
• W4387609716 cites W2069321794 @default.
• W4387609716 cites W2073420511 @default.
• W4387609716 cites W2074576643 @default.
• W4387609716 cites W2078169352 @default.
• W4387609716 cites W2080436457 @default.
• W4387609716 cites W2081735359 @default.
• W4387609716 cites W2083522254 @default.
• W4387609716 cites W2084511688 @default.
• W4387609716 cites W2096027508 @default.
• W4387609716 cites W2099447687 @default.
• W4387609716 cites W2099835784 @default.
• W4387609716 cites W2101380428 @default.
• W4387609716 cites W2103017472 @default.
• W4387609716 cites W2103071556 @default.
• W4387609716 cites W2110065044 @default.
• W4387609716 cites W2111074132 @default.
• W4387609716 cites W2113690827 @default.
• W4387609716 cites W2117122175 @default.
• W4387609716 cites W2126247355 @default.
• W4387609716 cites W2128149258 @default.
• W4387609716 cites W2129935236 @default.
• W4387609716 cites W2130045980 @default.
• W4387609716 cites W2134539328 @default.
• W4387609716 cites W2136902554 @default.
• W4387609716 cites W2138474420 @default.
• W4387609716 cites W2141589190 @default.
• W4387609716 cites W2144677406 @default.
• W4387609716 cites W2146512944 @default.
• W4387609716 cites W2147598859 @default.
• W4387609716 cites W2149671003 @default.
• W4387609716 cites W2151324279 @default.
• W4387609716 cites W2152979067 @default.
• W4387609716 cites W2153270694 @default.
• W4387609716 cites W2159193222 @default.
• W4387609716 cites W2159427817 @default.
• W4387609716 cites W2164244124 @default.
• W4387609716 cites W2164823776 @default.
• W4387609716 cites W2166150927 @default.
• W4387609716 cites W2168035834 @default.
• W4387609716 cites W2168879529 @default.
• W4387609716 cites W2170515238 @default.

• next